JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M311496200 on January 15, 2004

J. Biol. Chem., Vol. 279, Issue 15, 14679-14685, April 9, 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/15/14679    most recent
M311496200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Surana, N. K.
Right arrow Articles by St. Geme, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Surana, N. K.
Right arrow Articles by St. Geme, J. W., III
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Haemophilus influenzae Hia Autotransporter Contains an Unusually Short Trimeric Translocator Domain*

Neeraj K. Surana{ddagger}§, David Cutter{ddagger}, Stephen J. Barenkamp¶, and Joseph W. St. Geme, III{ddagger}||

From the {ddagger}Edward Mallinckrodt Department of Pediatrics and Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110 and the Department of Pediatrics, St. Louis University School of Medicine, St. Louis, Missouri 63104

Received for publication, October 20, 2003 , and in revised form, January 14, 2004.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Gram-negative bacterial autotransporter proteins are a growing group of virulence factors that are characterized by their ability to cross the outer membrane without the help of accessory proteins. A conserved C-terminal {beta}-domain is critical for targeting of autotransporters to the outer membrane and for translocation of the N-terminal "passenger" domain to the bacterial surface. We have demonstrated previously that the Haemophilus influenzae Hia adhesin belongs to the autotransporter family, with translocator activity residing in the C-terminal 319 residues. To gain further insight into the mechanism of autotransporter protein translocation, we performed a structure-function analysis on Hia. In initial experiments, we generated a series of in-frame deletions and a set of chimeric proteins containing varying regions of the Hia C terminus fused to a heterologous passenger domain and discovered that the final 76 residues of Hia are both necessary and sufficient for translocation. Analysis by flow cytometry revealed that the region N-terminal to this shortened translocator domain is surface localized, further suggesting that this region is not involved in {beta}-barrel formation or in translocation of the passenger domain. Western analysis demonstrated that the translocation-competent regions of the C terminus migrated at masses consistent with trimers, suggesting that the Hia C terminus oligomerizes. Furthermore, fusion proteins containing a heterologous passenger domain demonstrated that similarly small C-terminal regions of Yersinia sp. YadA and Neisseria meningitidis NhhA are translocation-competent. These data provide experimental support for a unique subclass of autotransporters characterized by a short trimeric translocator domain.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Secretion of proteins in Gram-negative bacteria is complicated by the presence of two membranes in the cell envelope. To overcome this barrier, organisms have evolved a variety of protein secretion systems that differ, in part, by the mechanism of translocation across the outer membrane. In some cases, translocation across the outer membrane is accomplished via a channel that spans the cytoplasmic membrane, periplasm, and outer membrane, allowing translocation of the protein directly from the cytoplasm to the extracellular milieu. In other cases, the polypeptide is transported across the cytoplasmic membrane and into the periplasm via the Sec apparatus and then is translocated across the outer membrane by a pore-forming complex. The individual pathways of this latter class of protein secretion systems are defined by the nature of the pore formed in the outer membrane. For example, the secretin proteins of the Type II secretion pathway form very large ring-shaped structures, with 10–14 subunits giving rise to a pore with an external diameter of 14–20 nm and an internal diameter of 5–10 nm (1). The PapC usher required for the assembly of P pili on uropathogenic Escherichia coli forms a hexameric ring, with an external diameter of ~12 nm and an internal diameter of ~2 nm (2). Autotransporter proteins, named for their ability to traverse the outer membrane without the assistance of accessory proteins, have long been thought to be translocated through a monomeric pore. However, recent evidence presented by Veiga et al. (3) suggests that the pore formed by the Neisseria gonorrhoeae IgA1 protease is oligomeric, with at least six subunits, and has an external diameter of ~9 nm and an internal diameter of ~2 nm.

Autotransporters are a rapidly growing family of proteins that are being recognized increasingly as virulence factors in pathogenic bacteria. These proteins are present in diverse organisms and mediate a wide array of functions, including proteolysis, adherence, invasion, and cytotoxicity (4). Members of the autotransporter family are characterized by three domains. An N-terminal signal sequence directs the polypeptide through the Sec apparatus and into the periplasm. A C-terminal {beta}-domain then integrates into the outer membrane and forms a pore, allowing the internal "functional" domain, referred to as the passenger domain, to be presented on the bacterial surface (4). In the vast majority of cases, the passenger domain is cleaved from the {beta}-domain and then either released into the extracellular medium or non-covalently tethered to the bacterial surface. Given the vast differences in passenger domain functions, the defining characteristic of an autotransporter lies in the ability of the {beta}-domain to translocate the passenger domain. The distinctive nature of this translocation process has resulted in a great deal of study. Deletion analyses performed with a number of autotransporters have shown that the {beta}-domain is generally ~300 residues in length (5–7). Secondary structure analyses of the {beta}-domain of autotransporters predict that this region has an {alpha}-helix transmembrane strand followed by 14 transmembrane {beta}-strands, which are believed to form a {beta}-barrel (6–9). In contrast, recent evidence has shown that the trimer-forming C-terminal 70 residues of Yersinia sp. YadA are capable of translocating an N-terminal epitope tag to the surface, leading the authors to suggest that YadA belongs to a distinct subfamily of oligomeric autotransporters (10).

In a previous work (11), we demonstrated that the Haemophilus influenzae Hia adhesin is an autotransporter protein, establishing that residues 780–1098 harbor translocator activity. More recently, we discovered that Hia contains two distinct binding domains, both of which mediate attachment to epithelial cells via the same host cell receptor, although with differing affinities (12). The primary high affinity binding domain resides within residues 541–714, whereas the secondary binding domain is contained in residues 50–374 and binds to host cells with ~20-fold decreased affinity. In the present study, we examined the Hia {beta}-domain in greater detail. Using a series of deletion mutants and chimeric proteins, we found that the C-terminal 76 residues are both necessary and sufficient for translocation of a passenger domain. In addition, we discovered that the Hia C terminus oligomerizes, forming a trimer. Further analyses revealed that the C termini of YadA and Neisseria meningitidis NhhA are sufficient for surface localization of foreign polypeptides. Our results extend previous work performed with YadA and clearly demonstrate the existence of a subfamily of autotransporter proteins, typified by a short translocator domain that undergoes trimer formation to form a {beta}-barrel.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Bacterial Strains, Plasmids, and Culture Conditions—Non-typable H. influenzae (NTHi) strain 11 is the strain from which hia was originally cloned and has been described previously (13). NTHi strain 32 was recovered from the middle ear fluid of a child with acute otitis media. Laboratory strains employed in these studies included H. influenzae strain DB117 (rec1–) (14), E. coli strain DH5{alpha} (Invitrogen), and E. coli BL21(DE3) (15). N. meningitidis strain BB-1148 is a serotype C strain and was a generous gift from Carl Frasch (Food and Drug Administration, Bethesda, MD).

The plasmid pHapS243A is a derivative of pGJB103 containing the hap gene from H. influenzae strain N187 with a point mutation at the codon encoding the active-site serine (9). The plasmid pDH106 contains the coding sequence for the Hap passenger domain (residues 1–1034) with an engineered SalI site at the 3'-end (16). The plasmid pHMW8-7 contains hia from H. influenzae strain 11 in pT7-7, and pHMW8-6 contains hia interrupted with a kanamycin cassette (13). The plasmid pHMW32-1 contains hia from NTHi strain 32 cloned into the SalI and EcoRI sites of pT7-7. The plasmid pHAT10 encodes a novel polyhistidine epitope tag, with six histidine residues spread throughout 19 amino acids (KDHLIHNVHKEEHAHAHNK), and strong affinity for immobilized metal ions (Clontech). The plasmid pMW10 encodes YadA from Yersinia enterocolitica serotype O:8 and was a kind gift from Virginia Miller (Washington University, St. Louis, MO).

E. coli strains were grown on Luria-Bertani (LB) agar or in LB broth and stored at –80 °C in LB broth with 50% glycerol. H. influenzae strains were grown on chocolate agar, on brain-heart infusion agar supplemented with hemin and NAD, or in brain-heart infusion broth supplemented with hemin and NAD, as described previously (17). Antibiotic concentrations used to select for plasmids included 100 µgml–1 ampicillin and 12.5 µg ml–1 tetracycline in E. coli and 5 µg ml–1 tetracycline in H. influenzae.

Recombinant DNA Methods—DNA ligations, restriction endonuclease digestions, gel electrophoresis, and PCR were performed according to standard techniques (18). Plasmids were introduced into E. coli by electroporation (19). H. influenzae was transformed using the MIV method of Herriott et al. (20).

Inactivation of hia in H. influenzae Strain 32—To construct a H. influenzae strain 32 mutant deficient in expression of Hia, bacteria were transformed with linearized pHMW8-6. Transformants were selected by plating on brain-heart infusion agar supplemented with hemin, NAD, and 20 µg ml–1 kanamycin. Allelic exchange was confirmed by Southern analysis, and loss of Hia expression was confirmed by Western immunoblotting.

Construction of Plasmids Used in This Study—To generate in-frame deletions within Hia, we began with pHMW8-7. Using recombinant PCR, a 1.1-kb AlwNI-MfeI fragment with a deletion of coding sequence for residues 780–976, a 950-bp AlwNI-MfeI fragment with a deletion of coding sequence for residues 780–1022, and a 900-bp AlwNI-MfeI fragment with a deletion of coding sequence for residues 780–1046 were produced and inserted in place of the wild-type 1.7-kb AlwNI-MfeI fragment in pHMW8-7, generating constructs pHMW8-7{Delta}780-976, pHMW8-7{Delta}780-1022, and pHMW8-7{Delta}780-1046.

To generate plasmids encoding the HapS-Hia chimeras, pHMW8-7 was used as a template to amplify the coding sequence for Hia residues 780–1098, 977–1098, 1023–1098, and 1047–1098 with an engineered SalI site at the 5'-end and an engineered BamHI site at the 3'-end. These PCR products were digested with SalI and BamHI and then ligated into SalI-BamHI-digested pDH106, generating pUC19::HapS-Hia780–1098, pUC19::HapS-Hia977–1098, pUC19::HapS-Hia1023–1098, and pUC19::HapS-Hia1047–1098. These pUC19::HapS-Hia chimeras were then digested with PstI and BamHI, liberating the ~6-kb inserts. These inserts were then ligated into PstI-BglII-digested pGJB103, generating pHapS-Hia780–1098, pHapS-Hia977–1098, pHapS-Hia1023–1098, and pHapS-Hia1047–1098. Plasmids encoding the HapS-YadA and HapS-NhhA chimeras were generated in a similar manner. The coding sequences for YadA residues 325–422 and NhhA residues 473–591 were amplified using pMW10 and genomic DNA from BB-1148 as templates, respectively, with engineered SalI and BamHI sites as before. These PCR products were digested with SalI and BamHI and ligated into SalI-BamHI-digested pDH106, generating pUC19::HapS-YadA325–422 and pUC19::HapS-NhhA473–591. The ~5.5-kb inserts were liberated by digestion with PstI and BamHI and were subsequently ligated into PstI-BglII-digested pGJB103, generating pHapS-YadA325–422 and pHapS-NhhA473–591.

To generate constructs encoding the HAT1 epitope fused to varying Hia C-terminal regions, a fragment containing the hia promoter and coding sequence for the Hia signal sequence was amplified by PCR, engineering HindIII sites on both ends. After digestion with HindIII, the fragment was ligated into a HindIII-digested alkaline phosphatase-treated pHAT10, generating pHAT::HiaSS. Transformants with the proper orientation of the insert were identified by nucleotide sequencing. pUC19::HapS-Hia780–1098, pUC19::HapS-Hia977–1098, pUC19::HapS-Hia1023–1098, and pUC19::HapS-Hia1047–1098 were digested with SalI and BamHI to liberate inserts encoding Hia C-terminal regions. These inserts were then ligated into SalI-BamHI-digested pHAT::HiaSS, generating pHAT::Hia780–1098, pHAT::Hia977–1098, pHAT::Hia1023–1098, and pHAT::Hia1047–1098. The plasmid pHMW8-7 was used as a template to amplify the coding sequence for Hia residues 820–1098, 853–1098, 872–1098, 889–1098, 911–1098, 928–1098, 948–1098, and 990–1098 with an engineered SalI site at the 5'-end and an engineered BamHI site at the 3'-end. PCR products were digested with SalI and BamHI and ligated into SalI-BamHI-digested pHAT:HiaSS, generating pHAT::Hia820–1098, pHAT::Hia853–1098, pHAT::Hia872–1098, pHAT::Hia889–1098, pHAT::Hia911–1098, pHAT::Hia928–1098, pHAT::Hia948–1098, and pHAT::Hia990–1098. All constructs were examined by nucleotide sequencing to ensure that the inserts were in-frame and that all PCR products were free of mutations.

Cell Fractionation and Protein Analysis—Whole-cell sonicates were prepared by resuspending bacterial pellets in 10 mM HEPES (pH 7.4) and sonicating to clarity. Outer membrane proteins were recovered on the basis of Sarkosyl insolubility as described by Carlone et al. (21). Unless otherwise noted, whole-cell sonicates and outer membrane fractions were treated with 95% formic acid as described previously (22). Where indicated, bacteria were incubated with cross-linkers (dithiobis(succinimidyl propionate) or 3,3'-dithiobis (sulfosuccinimidyl propionate), Pierce) according to the manufacturer's instructions prior to preparation of outer membrane proteins. Proteins were resolved by SDS-PAGE using 7.5–15% polyacrylamide gels. To ensure that comparable amounts of protein were analyzed, similar volumes from cultures of similar density were loaded into each lane. Western blots were performed with a guinea pig polyclonal antiserum raised against Hia residues 50–252, a guinea pig polyclonal antiserum raised against HapS, or a rabbit polyclonal antiserum raised against the HAT epitope (Clontech). An anti-guinea pig or anti-rabbit IgG antiserum conjugated to horseradish peroxidase (Sigma) was used as the secondary antibody, and detection of antibody reactivity was accomplished by incubation of the membrane in a chemiluminescent substrate solution (Pierce) and exposure to film.

Flow Cytometry Analysis of Bacteria—For E. coli strains, bacteria were inoculated 1:25 from overnight cultures into LB broth containing 100 µg ml–1 ampicillin and were grown to an A600 {approx} 0.4. For H. influenzae strains, bacteria were resuspended from a plate into brain-heart infusion broth supplemented with hemin and NAD to an A600 {approx} 0.2 and were grown to an A600 {approx} 0.8. With each sample, 1 ml of bacteria was fixed for 30 min with 4% paraformaldehyde phosphate-buffered saline, washed once with Tris-buffered saline, and resuspended in 0.5 ml of Tris-buffered saline containing 50 mM EDTA, 0.1% bovine serum albumin, and the appropriate primary antibody diluted 1:1000. Samples were washed twice with phosphate-buffered saline and resuspended in 0.25 ml of Tris-buffered saline containing 50 mM EDTA, 0.1% bovine serum albumin, and Cy2-conjugated secondary antibody (Jackson ImmunoResearch; 1:100). Incubations with the primary and secondary antibodies were for 1 h each. After incubation with the secondary antibody, samples were washed twice with phosphate-buffered saline, and surface-localized protein was measured by flow cytometry on a FACSCalibur (BD Biosciences). Data were analyzed with Cellquest software (BD Biosciences).

Quantitative Adherence Assays—Adherence assays were performed with Chang epithelial cells (Wong-Kilbourne derivative, clone 1-5c-4, human conjunctiva, ATCC CCL20.2) or with A549 respiratory epithelial cells (ATCC CCL185) as described previously (23). Percent adherence was calculated by dividing the number of adherent colony-forming units/monolayer by the number of colony-forming units inoculated.

Nucleotide Sequencing and DNA and Protein Sequence Analysis— Nucleotide sequencing was performed using an Applied Biosystems automated sequencer and the BigDye Terminator Premix-20 kit (Applied Biosystems/PerkinElmer Life Sciences). Double-stranded plasmid DNA was used as template, and sequencing was carried out along both strands. Amino acid sequence alignments were performed using ClustalW at EBI (ebi.ac.uk/clustalw/).

Nucleotide Sequence Accession Numbers—The nucleotide sequence for hia from NTHi strain 32 has been deposited with GenBank and assigned the accession number AY443498 [GenBank] .


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
The C-terminal 76 Residues of Hia Are Necessary and Sufficient for Translocator Activity—In initial studies, we compared the full-length Hia sequences from 10 different clinical isolates of NTHi and found significant overall similarity throughout the entire protein sequence. However, the protein expressed by strain 32 (Hia32) was found to be exceptional, lacking the sequence corresponding to residues 590–976 of Hia from the prototypic strain 11 (Hia11) (Fig. 1A). Interestingly, as shown in Fig. 1B, this truncation results in loss of the N-terminal seven {beta}-strands of the predicted {beta}-domain. Examination of outer membrane fractions by immunoblotting and surface-localized protein by flow cytometry revealed appreciable amounts of Hia in the outer membrane and on the surface of strain 32 (data not shown). Comparison of wild-type strain 32 and an isogenic Hia-deficient mutant (32hia) revealed that Hia32 was capable of mediating high levels of adherence to Chang cells, comparable with adherence by Hia11 (Fig. 1C). Consistent with this result, E. coli DH5{alpha} expressing Hia32 was highly adherent (Fig. 1C).



View larger version (22K):
[in this window]
[in a new window]
  		FIG. 1.
Analysis of Hia32. A, schematic comparison of the domain organization of Hia from NTHi strains 11 and 32. The blackened box labeled SP indicates the signal peptide. The horizontal line in Hia32 connecting the passenger domain and the {beta}-domain represents a missing sequence. B, predicted secondary structure of the Hia11 C terminus (residues 779–1098) based on the methods of Rost and Sander (37), Chou and Fasman (38), Schirmer and Cowan (39). Transmembrane {beta}-strands are shown in rectangles and total 14 (broken lines indicate weakly predicted {beta}-strands). An {alpha}-helix is shown in a cylinder. The shaded diamond, circle, square, and triangle indicate residues 780, 977, 1023, and 1047, respectively. The arrowheads depict starting residues for HAT-tagged Hia C-terminal regions. C, adherence to Chang epithelial cells by strains expressing Hia11 or Hia32. Bars represent the means ± S.E. wt, wild type.

 
With this information in mind, we hypothesized that the functional translocator domain of Hia from other isolates may also be smaller than recognized previously. To explore this possibility, we constructed a series of in-frame deletions within the Hia11 C terminus, allowing the examination of progressively shorter regions of the Hia C terminus for the ability to translocate the Hia passenger domain. Western analysis demonstrated that all deletion mutants except for Hia{Delta}780–1046 were properly inserted into the outer membrane (Fig. 2A). Flow cytometry analysis using an antiserum raised against residues 221–658 of Hia11 revealed that full-length Hia, Hia{Delta}780–976, and Hia{Delta}780–1022 were all surface-localized, whereas the passenger domain in Hia{Delta}780–1046 was absent from the bacterial surface (Fig. 2B). Consistent with these flow cytometry data, in adherence assays with Chang cells, E. coli BL21(DE3) expressing Hia{Delta}780–976 or Hia{Delta}780–1022 was capable of wild-type levels of adherence. In contrast, BL21(DE3) expressing Hia{Delta}780–1046 was non-adherent, indistinguishable from BL21(DE3) harboring vector alone (Fig. 2C).



View larger version (19K):
[in this window]
[in a new window]
  		FIG. 2.
Immunoblot and functional analysis of Hia deletion mutants expressed in E. coli BL21(DE3). A, outer membrane proteins detected by Western blot with a guinea pig antiserum directed against Hia residues 50–252. B, flow cytometry analysis of Hia on the bacterial surface performed with a guinea pig antiserum against Hia residues 221–658. Strain BL21(DE3)/pT7-7 (vector) was used as the negative control, and the corresponding histogram was superimposed (solid line) on results with E. coli expressing wild-type Hia (pHMW8-7) or the Hia deletion derivatives (filled histograms). C, adherence to Chang epithelial cells by E. coli BL21(DE3) expressing the indicated constructs. Bars represent the means ± S.E.

 
To extend these results, we generated fusions between the passenger domain of the H. influenzae Hap adhesin (HapS) and regions of the Hia C terminus comparable with those examined in the Hia deletion mutants. Hap has been shown previously to be an autotransporter that promotes microcolony formation and mediates adherence to cultured epithelial cells and extracellular matrix proteins (9, 24). After translocation of the passenger domain (HapS) to the bacterial surface, Hap undergoes an autoproteolytic cleavage event that releases HapS into the extracellular milieu. Mutating the active site serine to an alanine (HapS243A) prevents this cleavage event, locking the adhesin in a fully cell-associated form and thus enhancing adhesive properties (9). HapS243A was used as a positive control in these experiments, as the HapS-Hia fusions lack the cleavage sites normally present in Hap. Western analysis of outer membranes prepared from H. influenzae DB117 expressing HapS243A, HapS-Hia780–1098, HapS-Hia977–1098, HapS-Hia1023–1098, or HapS-Hia1047–1098 revealed that all the chimeras except HapS-Hia1047–1098 were present in the outer membrane, albeit at reduced levels compared with HapS243A (Fig. 3A). Furthermore, flow cytometry analysis confirmed the presence of HapS on the bacterial surface for all constructs except HapS-Hia1047–1098 (Fig. 3B). Consistent with these data, all the chimeras except HapS-Hia1047–1098 were capable of promoting appreciable bacterial adherence to A549 cells, although to a lesser level than HapS243A (Fig. 3C). Considered together, these results indicate that the C-terminal 76 residues of Hia are both necessary and sufficient for translocation of a passenger domain.



View larger version (21K):
[in this window]
[in a new window]
  		FIG. 3.
Immunoblot and functional analysis of HapS-Hia chimeras expressed in H. influenzae DB117. A, outer membrane proteins detected by Western blot with a guinea pig antiserum directed against HapS. B, flow cytometry analysis of HapS on the bacterial surface performed with a guinea pig antiserum against HapS. Strain DB117/pGJB103 (vector) was used as the negative control, and the corresponding histogram was superimposed (solid line) on results with DB117 expressing HapS243A or the HapS-Hia fusion proteins (filled histograms). C, adherence to A549 cells by DB117 expressing the indicated constructs. Bars represent the means ± S.E.

 
Given that the translocator domain is much smaller than previously believed, we elected to explore further the role of residues 780–1022. Specifically, we wondered whether residues 780–1022 form transmembrane {beta}-strands, as suggested by secondary structure predictions and depicted in Fig. 1B. One possibility is that these residues form additional transmembrane {beta}-strands that are dispensable for translocator activity but are important in other undetermined ways. Alternatively, this region may be completely surface-localized, thus explaining why it is not required for translocator activity. To discriminate between these possibilities, we generated constructs consisting of the Hia signal sequence and the HAT epitope fused upstream of progressively shorter regions of the Hia C terminus. The arrowheads in Fig. 1B identify the starting residues for these constructs, which address every predicted periplasmic and extracellular loop. Western analysis of outer membrane proteins prepared from bacteria expressing these constructs confirmed proper localization of all proteins except Hia1047–1098, which was not present in the outer membrane (data not shown). Furthermore, flow cytometry analysis revealed that the HAT epitope was surface localized in all cases except Hia1047–1098 (data not shown). These data indicate that residues 780–1022 are surface localized and do not form transmembrane {beta}-strands. Additionally, residues 1023–1046 are required for either Hia insertion into the outer membrane or Hia stability in the outer membrane.

The Hia C Terminus Undergoes Oligomerization—In considering the finding that the C-terminal 76 residues of Hia are able to translocate a passenger domain to the bacterial surface, we wondered about the mechanism by which this limited sequence might form a channel large enough to allow transit of the passenger domain. Studies performed with other outer membrane proteins have revealed that all form {beta}-barrel structures with an even number of {beta}-strands (25). Furthermore, the smallest {beta}-barrels recognized to date are OmpA and OmpX, both consisting of eight {beta}-strands (25). However, based on our secondary structure predictions of the Hia C terminus, Hia1023–1098 contains a maximum of only five {beta}-strands (Fig. 1B). In this context, it is notable that when we have performed immunoblots on outer membrane proteins recovered from bacteria expressing wild-type Hia, we have observed higher order structures and have speculated that these may represent multimers (13). Accordingly, we hypothesized that the Hia C terminus undergoes oligomerization, incorporating a larger number of {beta}-strands and forming a more typical {beta}-barrel.

To test this hypothesis, we isolated outer membrane proteins from E. coli DH5{alpha} expressing HAT-tagged Hia1023–1098, resolved these proteins under standard denaturing conditions, and examined them by Western analysis. As shown in Fig. 4 (left lane), Hia1023–1098 migrated at a molecular mass consistent with a trimer. In contrast, when treated with formic acid, the sample migrated at its predicted molecular mass (Fig. 4, right lane). Samples resolved by native gel electrophoresis or prepared in the presence of a cross-linker did not reveal complexes larger than a trimer (data not shown). These data demonstrate that Hia1023–1098 forms a trimer in the outer membrane.



View larger version (37K):
[in this window]
[in a new window]
  		FIG. 4.
Outer membrane proteins of BL21(DE3) harboring pHAT:Hia1023–1098 prepared in the absence (left lane) or presence (right lane) of formic acid treatment and detected with an antibody directed against the HAT epitope. The predicted monomeric mass of HAT-tagged Hia1023–1098 is 11 kDa.

 
The C Termini of YadA and NhhA Harbor Translocator Activity—Based on the fact that an epitope tag placed directly upstream of the C-terminal 70 residues of YadA is surface-localized, Roggenkamp et al. (10) speculated that YadA defines a subfamily of oligomeric autotransporters. To extend these findings and address whether the YadA C terminus truly harbors translocator activity and can present a functional polypeptide on the bacterial surface, we created a HapS-YadA325–422 chimera. In addition, to establish more definitively a subfamily of trimeric autotransporters with a short translocator domain, we examined the C terminus of N. meningitidis NhhA for translocator activity, generating a HapS-NhhA473–591 fusion protein. NhhA is an outer membrane protein that was first discovered upon sequencing the genome of strain MC58 and contains a C terminus that is highly conserved among diverse strains and serogroups and shares significant homology with the Hia and YadA C termini (26, 27). Adherence assays showed that both HapS-YadA325–422 and HapS-NhhA473–591 behaved like HapS-Hia1023–1098 and promoted attachment to A549 cells, indicating that both YadA and NhhA are autotransporters with short translocator domains (Fig. 5).



View larger version (18K):
[in this window]
[in a new window]
  		FIG. 5.
Identification of Yersinia sp. YadA and N. meningitidis NhhA as autotransporters. Adherence to A549 epithelial cells by H. influenzae DB117 expressing the indicated proteins. Bars represent the means ± S.E.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
In earlier work (11), we demonstrated that Hia belongs to the autotransporter family and established that Hia translocator activity resides within residues 780–1098. In the present study, we discovered that the Hia translocator domain is much smaller than recognized previously. In particular, the final 76 residues are sufficient to translocate both the Hia passenger domain and a heterologous protein, reflecting the capacity to form a trimer.

Examination of the Yersinia sp. YadA and N. meningitidis NhhA revealed that the C-terminal 98 amino acids of YadA and the C-terminal 119 amino acids of NhhA have translocator activity. In recent work, Roggenkamp et al. (10) demonstrated that the final 70 residues of YadA are sufficient for outer membrane localization and that epitopes N-terminal to this membrane anchor region are surface-localized, leading the authors to suggest that YadA belongs to a novel subfamily of autotransporters. Our results with HapS fusions extend the work of Roggenkamp et al. (10) and provide clear evidence that Hia, YadA, and NhhA belong to the same subfamily of autotransporter proteins with a small translocator domain.

Beyond possessing small translocator domains, Hia, YadA, and NhhA are unusual among autotransporters in several respects. For example, these three proteins lack the consensus sequence that defines the final 20 residues in almost all other known autotransporters (8). In addition, Hia, YadA, and NhhA lack the intramolecular chaperone domain required for proper folding of Bordetella pertussis BrkA and conserved in a diverse set of autotransporters (28). Finally, Hia and YadA are two of very few autotransporters wherein the passenger domain remains covalently attached to the {beta}-domain (there are currently no experimental data regarding this possibility for NhhA) (11, 29). In this context, it is notable that all proteins with a C terminus similar to Hia, YadA, and NhhA (defined by the conserved domain pfam03895) lack the consensus C-terminal sequence and the intramolecular chaperone domain. In addition, among the few proteins that have an Hia-like C terminus and have been characterized, the passenger domain uniformly remains covalently attached to the putative {beta}-domain. Together these observations provide further evidence that Hia-like autotransporters represent a distinct subfamily of autotransporter proteins.

Given the small size of the Hia translocator domain and previous work suggesting multimerization of the N. gonorrhoeae IgA1 protease {beta}-domain and the YadA C terminus (3, 10), we wondered whether the Hia translocator domain multimerizes. Indeed, we found that Hia1023–1098 exists in the outer membrane as a stable complex with a molecular mass consistent with a trimer. This observation is consistent with our recent finding that the primary binding domain of Hia also forms a trimer (40). Interestingly, Hia1047–1098 lacks translocator activity and fails to multimerize or insert into the outer membrane. The faint band observed in the outer membrane for Hia{Delta}780–1046 in Fig. 2A may be because of trimerization of the passenger domain, partially compensating for the inability of Hia1047–1098 to oligomerize or insert into the outer membrane. An alternative explanation for the faint band is that Hia{Delta}780–1046 is partially degraded in the periplasm.

Earlier studies suggested that YadA oligomerizes via a coiled coil domain (29); however, Hia1023–1098 has no predicted coiled coil region and must therefore oligomerize via a different mechanism. It is possible that residues 1023–1046 of Hia are critical for multimerization and that oligomerization is a prerequisite for insertion into the outer membrane, perhaps explaining why Hia1047–1098 is not localized to the outer membrane. Based on the correlation between multimerization and insertion into the outer membrane of Hia, we propose that the translocator domain multimerizes in the periplasm and inserts into the outer membrane as a trimer. Of note, porin subunits oligomerize in the periplasm and are unable to insert into the outer membrane as monomers (25).

Considering the constraints governing {beta}-barrel formation (25), it is likely that Hia1023–1098 contains four, rather than the predicted five, {beta}-strands resulting in an even number of total {beta}-strands for the trimeric structure. Virtually all crystallized {beta}-barrel proteins with 12 or fewer {beta}-strands are unable to form a pore and have a shear number no larger than 12 (30). The one exception is TolC, which forms a 12-stranded {beta}-barrel with a central pore and has an unusually large shear number of 20, a critical determinant of pore formation (30, 31). Hia1023–1098 is predicted to form a pore and therefore may have a similarly large shear number. Furthermore, each Hia1023–1098 monomer probably contributes its {beta}-strands to a common {beta}-barrel, similar to TolC and {alpha}-hemolysin (31, 32).

Given the limited size of the Hia translocator domain, it is interesting to consider the state of the passenger domain during translocation. It is currently unclear whether secretion of autotransporter proteins occurs in a folded or unfolded state. Early studies of autotransporters performed using cholera toxin B or PhoA as heterologous passenger domains suggested that the passenger domain must be unfolded during translocation (7, 11, 33). However, more recent evidence indicates that at least some passenger domains may fold in the periplasm and remain folded during the translocation process (34, 35). The recently determined crystal structure of the Hia primary binding domain reveals that it has a diameter of 4.5 nm (40), significantly larger than the ~2-nm pore size of classic autotransporter {beta}-domains (3, 36). Moreover, it is difficult to envisage how the ~33-kDa Hia1023–1098 {beta}-barrel forms a pore with a 4.5-nm diameter, indirectly suggesting that the passenger domain must fold on the surface of the organism. It is interesting to speculate that concerted folding and trimer formation of the passenger domain on the bacterial surface may provide the driving force for translocation.

In the course of our experiments, we observed that bacteria expressing a fusion protein consisting of HapS and the C terminus of Hia, Yersinia sp. YadA, or N. meningitidis NhhA were not able to adhere to epithelial cells as well as bacteria expressing HapS243A. This finding parallels observations with other chimeric autotransporter proteins (12, 16) and raises the possibility that a specific relationship exists between an autotransporter {beta}-domain and its native passenger domain. This relationship may depend on the oligomeric state and pore size of the {beta}-domain as well as the overall structure of the passenger domain, leading to more efficient translocation of a homologous rather than a heterologous peptide.

The finding that residues 780–1022 of Hia are not involved in the translocation process helps to resolve an apparent paradox related to Hia adhesive activity. As described in an earlier publication (12), we found that the Hia primary binding domain resides within residues 541–714, originally suggesting juxtaposition to the outer membrane and potential interference by other bacterial surface structures. Instead, residues 780–1022 are surface-localized, raising the possibility that this sequence serves as a spacer region, effectively distancing the primary binding domain from the bacterial surface and enhancing the likelihood of interaction with the host cell receptor.

It is intriguing to note that Hia32 contains only one binding domain, as identified by sequence homology. In contrast, Hia11 and the Hia sequences from other strains all contain two binding domains (12). Although sequence alignments cannot predict whether the Hia32 binding domain is functionally more similar to the Hia11 primary or secondary binding domain, the high levels of adherence attained with Hia32 suggest that its binding domain is analogous to the Hia11 primary binding domain. Further investigation is needed to address the precise nature of the Hia32 binding domain as well as the role of the Hia11 secondary binding domain.

To summarize, Hia, YadA, and NhhA appear to define a unique subfamily of autotransporters characterized by a short trimeric translocator domain. An improved understanding of structure-function relationships in these unusual translocator domains may provide general insights into bacterial protein secretion systems.


   FOOTNOTES
 
* This work was supported by United States Public Health Service Grants R01 AI44167 (to J. W. S.) and R01 AI48066 (to S. J. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY443498 [GenBank] . Back

§ Supported by Training Grant T32 AI0717223. A member of the Medical Scientist Training Program at Washington University School of Medicine. Back

|| To whom correspondence should be addressed: Dept. of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8208, St. Louis, MO 63110. Tel.: 314-286-2887; Fax: 314-286-2895; E-mail: stgeme{at}borcim.wustl.edu.

1 The abbreviation used is: HAT, histidine affinity tag. Back


   ACKNOWLEDGMENTS
 
We thank Sven Laarmann for general discussions and Shane Cotter for critical reading of the manuscript.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Stathopoulos, C., Hendrixson, D. R., Thanassi, D. G., Hultgren, S. J., St. Geme, J. W., III, and Curtiss, R., III (2000) Microbes Infect. 2, 1061–1072[CrossRef][Medline] [Order article via Infotrieve]
  2. Thanassi, D. G., Saulino, E. T., Lombardo, M. J., Roth, R., Heuser, J., and Hultgren, S. J. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 3146–3151[Abstract/Free Full Text]
  3. Veiga, E., Sugawara, E., Nikaido, H., de Lorenzo, V., and Fernandez, L. A. (2002) EMBO J. 21, 2122–2131[CrossRef][Medline] [Order article via Infotrieve]
  4. Henderson, I. R., Navarro-Garcia, F., and Nataro, J. P. (1998) Trends Microbiol. 6, 370–378[CrossRef][Medline] [Order article via Infotrieve]
  5. Klauser, T., Kramer, J., Otzelberger, K., Pohlner, J., and Meyer, T. F. (1993) J. Mol. Biol. 24, 579–593
  6. Maurer, J., Jose, J., and Meyer, T. F. (1999) J. Bacteriol. 181, 7014–7020[Abstract/Free Full Text]
  7. Suzuki, T., Lett, M. C., and Sasakawa, C. (1995) J. Biol. Chem. 270, 30874–30880[Abstract/Free Full Text]
  8. Loveless, B. J., and Saier, M. H., Jr. (1997) Mol. Membr. Biol. 14, 113–123[Medline] [Order article via Infotrieve]
  9. Hendrixson, D. R., de la Morena, M. L., Stathopoulos, C., and St. Geme, J. W., III (1997) Mol. Microbiol. 26, 505–518[CrossRef][Medline] [Order article via Infotrieve]
  10. Roggenkamp, A., Ackermann, N., Jacobi, C. A., Truelzsch, K., Hoffmann, H., and Heesemann, J. (2003) J. Bacteriol. 185, 3735–3744[Abstract/Free Full Text]
  11. St. Geme, J. W., III, and Cutter, D. (2000) J. Bacteriol. 182, 6005–6013[Abstract/Free Full Text]
  12. Laarmann, S., Cutter, D., Juehne, T., Barenkamp, S. J., and St. Geme, J. W., III (2002) Mol. Microbiol. 46, 731–743[CrossRef][Medline] [Order article via Infotrieve]
  13. Barenkamp, S. J., and St. Geme, J. W., III (1996) Mol. Microbiol. 19, 1215–1223[Medline] [Order article via Infotrieve]
  14. Setlow, J. K., Brown, D. C., Boling, M. E., Mattingly, A., and Gordon, M. P. (1968) J. Bacteriol. 95, 546–558[Abstract/Free Full Text]
  15. Studier, F. W., and Moffatt, B. A. (1986) J. Mol. Biol. 189, 113–130[CrossRef][Medline] [Order article via Infotrieve]
  16. Hendrixson, D. R., and St. Geme, J. W., III (1998) Mol. Cell 2, 841–850[CrossRef][Medline] [Order article via Infotrieve]
  17. Anderson, P., Johnston, R. B., Jr., and Smith, D. H. (1972) J. Clin. Investig. 51, 31–38[Medline] [Order article via Infotrieve]
  18. Sambrook, J., and Russel, D. W. (2001) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  19. Dower, W. J., Miller, J. F., and Ragsdale, C. W. (1988) Nucleic Acids Res. 16, 6127–6145[Abstract/Free Full Text]
  20. Herriott, R. M., Meyer, E. M., and Vogt, M. (1970) J. Bacteriol. 101, 517–524[Abstract/Free Full Text]
  21. Carlone, G. M., Thomas, M. L., Rumschlag, H. S., and Sottnek, F. O. (1986) J. Clin. Microbiol. 24, 330–332[Abstract/Free Full Text]
  22. St. Geme, J. W., III, Kumar, V. V., Cutter, D., and Barenkamp, S. J. (1998) Infect. Immun. 66, 364–368[Abstract/Free Full Text]
  23. St. Geme, J. W., III, Falkow, S., and Barenkamp, S. J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2875–2879[Abstract/Free Full Text]
  24. Fink, D. L., Buscher, A. Z., Green, B., Fernsten, P., and St. Geme, J. W., III (2003) Cell. Microbiol. 5, 175–186[CrossRef][Medline] [Order article via Infotrieve]
  25. Schulz, G. E. (2000) Curr. Opin. Struct. Biol. 10, 443–447[CrossRef][Medline] [Order article via Infotrieve]
  26. Peak, I. R., Srikhanta, Y., Dieckelmann, M., Moxon, E. R., and Jennings, M. P. (2000) FEMS Immunol. Med. Microbiol. 28, 329–334[CrossRef][Medline] [Order article via Infotrieve]
  27. Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Arico, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., Galeotti, C. L., Luzzi, E., Manetti, R., Marchetti, E., Mora, M., Nuti, S., Ratti, G., Santini, L., Savino, S., Scarselli, M., Storni, E., Zuo, P., Broeker, M., Hundt, E., Knapp, B., Blair, E., Mason, T., Tettelin, H., Hood, D. W., Jeffries, A. C., Saunders, N. J., Granoff, D. M., Venter, J. C., Moxon, E. R., Grandi, G., and Rappuoli, R. (2000) Science 287, 1816–1820[Abstract/Free Full Text]
  28. Oliver, D. C., Huang, G., Nodel, E., Pleasance, S., and Fernandez, R. C. (2003) Mol. Microbiol. 47, 1367–1383[CrossRef][Medline] [Order article via Infotrieve]
  29. Hoiczyk, E., Roggenkamp, A., Reichenbecher, M., Lupas, A., and Heesemann, J. (2000) EMBO J. 19, 5989–5999[CrossRef][Medline] [Order article via Infotrieve]
  30. Schulz, G. E. (2002) Biochim. Biophys. Acta 1565, 308–317[Medline] [Order article via Infotrieve]
  31. Koronakis, V., Sharff, A., Koronakis, E., and Luisi, B. (2000) Nature 405, 914–919[CrossRef][Medline] [Order article via Infotrieve]
  32. Song, L., Hobaugh, M. R., Shustak, C., Cheley, S., Bayley, H., and Gouaux, J. E. (1996) Science 274, 1859–1866[Abstract/Free Full Text]
  33. Klauser, T., Pohlner, J., and Meyer, T. F. (1992) EMBO J. 11, 2327–2335[Medline] [Order article via Infotrieve]
  34. Brandon, L. D., and Goldberg, M. B. (2001) J. Bacteriol. 183, 951–958[Abstract/Free Full Text]
  35. Veiga, E., de Lorenzo, V., and Fernandez, L. A. (1999) Mol. Microbiol. 33, 1232–1243[CrossRef][Medline] [Order article via Infotrieve]
  36. Shannon, J. L., and Fernandez, R. C. (1999) J. Bacteriol. 181, 5838–5842[Abstract/Free Full Text]
  37. Rost, B., and Sander, C. (1993) J. Mol. Biol. 232, 584–599[CrossRef][Medline] [Order article via Infotrieve]
  38. Chou, P. Y., and Fasman, G. D. (1979) Biophys. J. 26, 367–384[Abstract/Free Full Text]
  39. Schirmer, T., and Cowan, S. W. (1993) Protein Sci. 2, 1361–1363[Medline] [Order article via Infotrieve]
  40. Yeo, H.-J., Cotter, S. E., Laarmann, S., Juehne, T., St. Geme, J. W., III, and Waksman, G. (2004) EMBO J., in press

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Bacteriol.Home page
N. Ackermann, M. Tiller, G. Anding, A. Roggenkamp, and J. Heesemann
Contribution of Trimeric Autotransporter C-Terminal Domains of Oligomeric Coiled-Coil Adhesin (Oca) Family Members YadA, UspA1, EibA, and Hia to Translocation of the YadA Passenger Domain and Virulence of Yersinia enterocolitica
J. Bacteriol., July 15, 2008; 190(14): 5031 - 5043.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
J. Valle, A. N. Mabbett, G. C. Ulett, A. Toledo-Arana, K. Wecker, M. Totsika, M. A. Schembri, J.-M. Ghigo, and C. Beloin
UpaG, a New Member of the Trimeric Autotransporter Family of Adhesins in Uropathogenic Escherichia coli
J. Bacteriol., June 15, 2008; 190(12): 4147 - 4161.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
A. J. Sheets, S. A. Grass, S. E. Miller, and J. W. St. Geme III
Identification of a Novel Trimeric Autotransporter Adhesin in the Cryptic Genospecies of Haemophilus
J. Bacteriol., June 15, 2008; 190(12): 4313 - 4320.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
C. Yu, T. Ruiz, C. Lenox, and K. P. Mintz
Functional Mapping of an Oligomeric Autotransporter Adhesin of Aggregatibacter actinomycetemcomitans
J. Bacteriol., May 1, 2008; 190(9): 3098 - 3109.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
M. Desvaux, A. Scott-Tucker, S. M. Turner, L. M. Cooper, D. Huber, J. P. Nataro, and I. R. Henderson
A conserved extended signal peptide region directs posttranslational protein translocation via a novel mechanism
Microbiology, January 1, 2007; 153(1): 59 - 70.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. Ruiz, C. Lenox, M. Radermacher, and K. P. Mintz
Novel Surface Structures Are Associated with the Adhesion of Actinobacillus actinomycetemcomitans to Collagen.
Infect. Immun., November 1, 2006; 74(11): 6163 - 6170.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
C. A. Seers, N. Slakeski, P. D. Veith, T. Nikolof, Y.-Y. Chen, S. G. Dashper, and E. C. Reynolds
The RgpB C-Terminal Domain Has a Role in Attachment of RgpB to the Outer Membrane and Belongs to a Novel C-Terminal-Domain Family Found in Porphyromonas gingivalis.
J. Bacteriol., September 1, 2006; 188(17): 6376 - 6386.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
S. E. Cotter, N. K. Surana, S. Grass, and J. W. St. Geme III
Trimeric autotransporters require trimerization of the passenger domain for stability and adhesive activity.
J. Bacteriol., August 1, 2006; 188(15): 5400 - 5407.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
D. S. H. Kim, Y. Chao, and M. H. Saier Jr
Protein-translocating trimeric autotransporters of gram-negative bacteria.
J. Bacteriol., August 1, 2006; 188(16): 5655 - 5667.
[Full Text] [PDF]

Home page
 Infect. Immun.